Cancer drugs rank among the most counterfeited medicines in Kenya, posing significant risks to patients. These falsified treatments may contain incorrect ingredients or lack active medicinal components altogether.
The Pharmacy and Poisons Board (PPB) has identified that fast-moving, high-value medicines, particularly those used for cancer treatment and specialized medical procedures, are especially susceptible to counterfeiting.
This alarming trend underscores the urgent need for enhanced regulatory measures and public awareness to protect patients from the dangers of counterfeit medications.